In vivo and in vitro evaluation of 177Lu-labeled DOTA-2-deoxy-D-glucose in mice. A novel radiopharmaceutical agent for cells imaging and therapy.
Sign Up to like & getrecommendations! Published in 2019 at "Hellenic journal of nuclear medicine"
DOI: 10.1967/s002449911002
Abstract: OBJECTIVE Incorporation of lutetium-177 (177Lu) into suitable molecules that are implicated in cancer pathology represents a promising approach for the diagnosis and treatment of cancer. The goal of the present study was to develop a… read more here.
Keywords: radiopharmaceutical agent; dota; 177lu labeled; 177lu dota ... See more keywords